Abstract:Objective:To investigate the serum lipoprotein associated phospholipase A2 (LP-PLA2) and nonesterified fatty acid (NEFA) level of coronary heart disease (CHD) patients,and explore the relation between the indexes and pathologic characters of CHD and postoperative prognosis of percutaneous coronary intervention (PCI).Method:According to the results of coronary angiography,the total 589 experimental subjects come from department of cardiovascular medicine were divided into four groups:189 for control subjects,117 for single-vessel disease group,126 for double-vessel disease group and 157 for multi-vessel disease group.The blood samples were collected from the venous blood of the elbow of every patients.In the meanwhile,the blood samples of 166 patients who underwent PCI surgery were collected before the surgery,6 hours after,12 hours after,24 hours after and 48 hours after the surgery,and the level of serum LP-PLA2 and NEFAlevel were detected by Automatic biochemical analyzer.The differences in serum PLP-PLA2 and NAFE level were compared between different groups of patients and patients with PCI.Results:Compared with the group of control(209.34±87.32U/L),the serum level of LP-PLA2 in the group of single-vessel disease (351.77±103.26U/L) and the group of double-vessel disease (409.14±196.34U/L) and the group of multi-vessel disease (823.65 ± 369.94 U/L) are significantly higher(P＜0.01),and the group of multi-vessel disease ＞ the group of double-vessel disease ＞ the group of single-vessel disease.The serum level of NEFA in the group of multi-vessel disease(0.92±0.49mmol/L)and the group of double-vessel disease (0.56±0.13mmol/L)and the group of single-vessel disease (1.22±0.8mmol/L) are significantly higher then the group of control subjects(0.23±0.07mmol/L)(P＜0.01).And the group of multi-vessel disease ＞ the group of double-vessel disease ＞ the group of single-vessel disease.In addition,compared with the control subjects,the serum LP-PLA2 level after the PCI surgery 6 hours (644.64±361.34U/L vs 286.12±188.32U/L,P＜0.01) is significantly higher before the surgery,and after 12 hours of the surgery(452.57±245.56U/L),and 24 hours of the surgery (385.23±132.47U/ L) and 48 hours of the surgery (325.78±144.97U/L),are continue to decrease,which is statistically significant difference compared with each other (P＜0.01).There is no significant difference of the serum level of NEFA before and after the PCI operation(P＞0.05).Conclusion:The serum levels of LP-PLA2 and NEFA are closely associated with endothelial dysfunction andvascular endothelial function and arterial wall which have important clinical significance in assessment of the lesion severity of coronary arter in CHD patients.

Relationship Between Plasma ⅡA Secretory Phospholipase A2 and Restenosis after Percutanous Coronary Intervention in Patients with Coronary Heart Disease

Relationship of Secretory Type Ⅱ Phospholipase A2, Coronary Artery Score and Atherogenic Index in Patients with Coronary Artery Disease

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

Study on Relationship Between Plasma Group IIA Secretory Phospholipase A_2 and Coronary Heart Disease

To Explore the Relationship between Clinical Serum Markers and Intracoronary in-stent Restenosis

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

The Study of the Relation between Serum Lipoprotein Associated Phospholipase A2 or Non-esterified Fatty Acid and Pathologic Characters of Coronary Artery in CHD Patients

Relationship Between Plasma Level of IL-18,ox-LDL and the Development of Emergency Percutaneous Coronary Intervention

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Relationship between pregnancy-associated plasma protein A level and restenosis after elective coronary stenting

Relationship Between Interleukin-18 Levels and Characterization of Atherosclerotic Plaque and Percutaneous Coronary Intervention

Relationship Between Coronary Atherosclerotic Plaque and Secretory Type Ⅱ Phospholipase A2,Hypersensitive C-Reactive Protein

Association Between Plasma Pregnancy-Associated Plasma Protein a and Restenosis after Percutaneous Coronary Angioplasty.

The Correlation Between Lipoprotein-Associated Phospholipase A2 and Severity of Coronary Artery Diseases

Predictive value of lipoprotein-associated phospholipase A2 on perioperative myocardial injury in patients with stable angina after percutaneous coronary intervention

Relationship Between Lipid Control Level and In-stent Restenosis in Patients After Percutaneous Coronary Intervention

[Elevated Serum Secretory Type II Phospholipase A2 in Patients with Coronary Heart Disease].

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Progression Of Nonculprit Lesions After Percutaneous Coronary Intervention

An observational study on aortic plasma levels of angiotensin II and plasminogen activator inhibitor-1 in patients with coronary artery stenosis

The Value of Pregnancy Associated Plasma Protein A and IVS6+95 Gene Polymorphism in Prediction of Restenosis after Percutaneous Coronary Intervention

Effect of Devated Plasma Lipoprotein (a) on Restenosis after Stent Implantation